Denoised MDS-UPDRS Part-III Scores Yield New Patterns of Progression Heterogeneity in Early Stage Parkinson's Disease
Preprint
Abstract
Parkinson's Disease (PD) Motor Scores (MDS-UPDRS Part III) are quite noisy. This paper proposes a new methodology for processing these scores by first denoising the scores to enhance the underlying progression signal, and then conducting a high-dimensional analysis which does not sum the scores into a total movement score. The analysis gives novel insights into PD progression heterogeneity: it reveals that the heterogeneity is continuously variable rather than clustered into "subtypes" and that the variability is along two easily understood axes. This analysis also resolves some of the discrepancies in previously reported progression subtypes. Finally, the analysis reveals that patient-specific progression cannot be predicted from baseline using only MDS-UPDRS Part III scores.Keywords
Funding Information
- NIH (NINDS) (R01NS107328)
This publication has 57 references indexed in Scilit:
- Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson DiseaseJAMA Neurology, 2019
- Progression in the LRRK2-Associated Parkinson Disease PopulationJAMA Neurology, 2018
- Is PIGD a legitimate motor subtype in Parkinson disease?Annals of Clinical and Translational Neurology, 2016
- New Clinical Subtypes of Parkinson Disease and Their Longitudinal ProgressionJAMA Neurology, 2015
- The identification of Parkinson's disease subtypes using cluster analysis: A systematic reviewMovement Disorders, 2010
- Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson DiseaseArchives of Neurology, 2009
- The prevalence of Parkinson's disease in rural TanzaniaMovement Disorders, 2008
- Clinical characteristics in early Parkinson's disease in a central California population‐based studyMovement Disorders, 2005
- Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptakeMovement Disorders, 2000
- Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's diseaseAnnals of Neurology, 1995